OssDsign AB (publ) (OSSD.ST) Stock Analysis & Winston Score
OssDsign is a Swedish medical device company that makes custom implants used to repair bones in the skull and spine. Its main products are cranial and spinal fusion implants made from a calcium phosphate material designed to bond with the patient's own bone over time. The company sells primarily to hospitals and surgeons, with a focus on reconstructive and neurosurgery procedures. OssDsign earns revenue by selling these implants directly to hospitals, mainly in Europe and North America. The 95% gross margin reflects the high value of specialized surgical implants, but the company is still operating at a loss as it invests in sales expansion and clinical adoption. Its key competitive advantage is the proprietary biomaterial technology, which mimics natural bone and may reduce complications compared to traditional titanium implants. The main risk is that OssDsign is a small company competing against much larger medical device makers, and it needs to significantly grow its surgeon base and procedure volumes to reach profitability.
Winston Score: 26/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Good (11/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
